Aron E. Kefela, MD joined the cancer care team of Northwest Georgia Oncology Centers, P.C. (NGOC) in August 2014. Dr. Kefela treats all forms of cancer and blood disorders with a special interest in breast cancer. He completed his Fellowship in Hematology and Medical Oncology at Allegheny Health Network, Temple University in Pittsburgh, PA in June 2014 and completed his Internship and Residency in Internal Medicine at St. Vincent Hospital in Indianapolis, IN in 2009. Dr. Kefela received his Doctorate of Medicine from Indiana University School of Medicine in Indianapolis, IN.
He is actively involved in cancer research and clinical trials to find a cancer cure and provide patients with the most advanced cancer treatment available in Georgia.
|Undergraduate Education||Wayne State University
Indiana University, Master's Degree
|Medical Education||Doctor of Medicine
Indiana University, School of Medicine
St. Vincent Hospital
July 2006 - June 2007
St. Vincent Hospital
July 2007- June 2009
Hematology & Medical Oncology
Allegheny Health Network, Temple University
July 2011 – June 2014
|Board Certification||American Board of Internal Medicine, Internal Medicine, 2010
American Board of Internal Medicine, Medical Oncology, 2014
American Board of Internal Medicine, Hematology, pending
|Medical Licensure||State of Georgia, 2014 (Active)
|Professional Societies||American Society of Clinical Oncology
American Society of Hematology
National Cancer Institute
|Honors||Department of Clinical Laboratory Science Scholarship, 1999
Dean's List, 1996-1999
Fludarabine, Intravenous Besulfan, and Total Body Irradiation (FluBuTBI) Conditioning for Allogeneic Peripheral Blood Stem Cell Transplantation, The Western Pennsylvania Cancer Institute, Aron Kefela, Entezam Sahovic, Jocelyn De Yao, Santhosh Sadashiv, James Rossetti, Salman Fazal, Cyrus Khan, Gina Berteotti, and John Lister. Presented at the American Society of Blood and Marrow Transplant and Center for International Blood and Marrow Transplant Research tandem meeting in February 2014.
MRI vs. Mammography to Evaluate the Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer, St. Vincent Hospital, Indianapolis, IN, Aron Kefela, MD, Ruemu Birhiray MD, Syed Moazzem, MD. Presented at the American Society of Breast Diseases in 2010.
|Research Activity||Clinical Trials (Oncology & Hematology)
-Retrospective study of safety and efficacy of Flu/BU/TBI conditioning regimen in allogeneic stem cell transplantation, July 2012-February 2014.
-Retrospective review of outcome of patients with early stage HER2/Neu positive breast cancer (Stage 1, T1a, T1b) who received Herceptin vs. those who did not, March 2013-June 2013.
-Accuracy of MRI vs. mammography in the evaluation of patients who received neoadjuvant treatment in minimally invasive breast cancer, August 2009-December 2009. Presented poster in ASBD Annual Symposium, New York, 2010.